Skip to main content

Animations

MJFF Publications

3851 - 3860 of 6451 Results
Title
Year
  • Year
  • 2022
  • 2016
  • 2024
  • 2024
  • 2023
  • 2019
  • 2020
  • 2020
  • 2024
  • 2019
  • Summary Details
    OPEN
    Title: Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-022-00554-8
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.07.013
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Clinical and neuroradiological spectrum of biallelic variants in NOTCH3
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2024.105297
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Pharmacodynamic, pharmacokinetic and rat brain receptor occupancy profile of NLX-112, a highly selective 5-HT1A receptor biased agonist
    Journal Name: Naunyn-Schmiedeberg's Archives of Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00210-024-03323-0
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Neuron-derived extracellular vesicles to examine brain mTOR target engagement with sirolimus in patients with multiple system atrophy
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105821
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Transportation innovation to aid Parkinson disease trial recruitment
    Journal Name: Contemporary Clinical Trials Communications
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.conctc.2019.100449
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Dietary antioxidants associated with slower progression of parkinsonian signs in older adults
    Journal Name: Nutritional Neuroscience
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/1028415x.2020.1769411
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Sex Disparities in Autonomic Symptom Treatment in Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12997
    Citation Count: 8
  • Summary Details
    OPEN
    Title: An adapted protocol to derive microglia from stem cells and its application in the study of CSF1R-related disorders
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-024-00723-x
    Citation Count: 16
  • Summary Details
    OPEN
    Title: No genetic evidence for involvement of alcohol dehydrogenase genes in risk for Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.11.006
    Citation Count: 14
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.